Norman de Greve Joins TextNow Board of Directors
Fortune 5 executive joins TextNow board to support the company's rapid growth and scaling.
FREMONT, CA: Norman de Greve, Chief Marketing Officer at CVS Health, joins TextNow, the leading free phone service provider’s Board of Directors. Norman will advise TextNow's senior leadership team, bringing decades of experience assisting companies in accelerating consumer-driven growth and differentiation. He has been named one of Fast Company's 100 Most Creative People in Business and one of The Internationalist's Most Inspiring Marketers of the Twenty-First Century. He was instrumental in transforming CVS from a neighborhood pharmacy to the nation's largest and most trusted health care company. He is currently the Chairman of the Mobile Marketing Association of North America and a non-profit Ad Council's Board of Directors. Before joining CVS, Norman served as President of Digitas' corporate headquarters. During his 14 years at Digitas, he assisted in the company's meteoric rise from regional to global.
“TextNow is a major disruptor enabling millions of people to have access to phone service without paying high fees,” says Norman. “I am excited to join Derek and the talented management team to accelerate the company’s growth.”
“Norman is one of the most influential marketers in North America, and we’re thrilled to have him on our team,” says Derek Ting, co-founder and CEO of TextNow. “We’ve spent the past year building out our executive team and positioning TextNow for rapid expansion, and Normans experience and expertise will help us continue to scale our business.”
TextNow has added six senior executives in the last year, including Chief Growth Officer Ken Willner, Chief Financial Officer and Chief Operating Officer Evan Fein, Senior Vice President of Engineering Andy Shin, Vice President of Monetization Josh Lustgarten, Vice President of Talent Suzanne Salzberg, and Vice President of People Kelsi Cochran. In June 2020, TextNow has also welcome experienced technology executive Paul Schaut to its board of directors.